Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Quality of Life and Cost Analysis of a Prospective Randomized Phase III Trial Comparing Trimodality Therapy to Surgery Alone for Esophageal Cancer [Companion to CALGB-9781]

NCT00003381 is registered in ClinicalTrials.gov with Alliance for Clinical Trials in Oncology as lead sponsor.

NCT NCT00003381
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00003381 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Quality of Life and Cost Analysis of a Prospective Randomized Phase III Trial Comparing Trimodality Therapy to Surgery Alone for Esophageal Cancer [Companion to CALGB-9781]
Lead sponsor
Alliance for Clinical Trials in Oncology
Phase
Observational
Overall status
Terminated
Start date
July 31, 1998
Completion date
January 31, 2005
Enrollment
56 (actual)
Sites
44

Conditions

As the registry lists them; a condition with its own page is linked.

esophageal cancer